Treatment-Continuity of ADHD Compared Using Immediate-Release and Extended-Release MPH

Authors

  • J Gordon Millichap Northwestern University Feinberg School of Medicine

DOI:

https://doi.org/10.15844/pedneurbriefs-19-7-5

Keywords:

Methylphenidate, Immediate-Release, Extended-Release

Abstract

The continuity of methylphenidate (MPH) therapy for ADHD in young Medicaid beneficiaries (ages 6 to 17 years) treated with immediate-release (IR) or extended-release (ER) MPH formulations was compared in an analysis of statewide California Medicaid claims (2000-2003) conducted at Columbia University, New York; University of Pennsylvania, Philadelphia; and McNeil Pharmaceuticals, Fort Washington, PA.

Published

2005-07-01

Issue

Section

Attention Deficit Disorders